Asfalia Biologics
Gene therapy development
- B2B
About Asfalia Biologics
A biotechnology company focused on developing safe gene transfer strategies for gene therapy
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2018
- Revenue
- $3.5M – $27.4MTamtam estimate
Asfalia Biologics at a glance
Asfalia Biologics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Asfalia Biologics was founded in 2018.
Asfalia Biologics has 1–10 employees.
Asfalia Biologics's revenue is $3.5M – $27.4M (Tamtam estimate).
Selling to companies like Asfalia Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies